Sunday, May 22, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Survey identifies maternal attitude towards COVID-19 vaccination during pregnancy

by Medical Finance
in Coronavirus
Study: Attitudes and Beliefs Associated With COVID-19 Vaccination During Pregnancy. Image Credit: Velishchuk Yevhen/Shutterstock
9
SHARES
102
VIEWS
Share on FacebookShare on Twitter

In a recent paper published in Jama Network Open, researchers designed a survey to investigate whether maternal beliefs were associated with coronavirus disease 2019 (COVID-19) vaccine-hesitancy during pregnancy, to devise strategies to address related issues.

Study: Attitudes and Beliefs Associated With COVID-19 Vaccination During Pregnancy. Image Credit: Velishchuk Yevhen/Shutterstock
Study: Attitudes and Beliefs Associated With COVID-19 Vaccination During Pregnancy. Image Credit: Velishchuk Yevhen/Shutterstock

Background

COVID-19 vaccines have demonstrated high efficacy in reducing obstetric complications throughout the pregnancy among women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Yet, COVID-19 vaccine acceptance in pregnancy remains low.

In the United States of America (USA), as of January 2022, only 24.4% of pregnant women received at least one vaccine dose during pregnancy, and barely 42.6% of pregnant women received a complete two-dose primary regimen of the COVID-19 vaccine.

About the study

In the present prospective study, researchers surveyed unvaccinated pregnant women at a healthcare center in the Medical College of Wisconsin, USA, between June and August 2021. For the study purposes, having received a COVID-19 vaccination meant a respondent had received at least one dose of the vaccine during pregnancy.

The COVID-19 Vaccine Attitudes in Pregnancy survey was adapted from a previously validated survey but modified based on clinical experience and existing literature. Nevertheless, it was easy to read and took less than 10 minutes to complete.

It comprised sociodemographic questions covering four broad domains –

i) perception towards immunization,

ii) general outlook towards SARS-CoV-2 infection,

iii) concerns regarding COVID-19 vaccine safety, and

iv) social and informational attitudes toward the COVID-19 vaccine

The team used three survey response formats, including dichotomous responses (yes or no), a five-point Likert scale (e.g., strongly disagree, not sure, strongly agree), and a similar 10-point scale.The primary outcome of the survey was to measure the strength of intention to receive the COVID-19 vaccine during pregnancy.

Furthermore, the team used factor analysis to determine the optimal number of grouping survey items under a pooled comprehensive paradigm. When initial grouping linked conceptually similar areas of questioning, survey items loaded on the identified factors. Factor analysis confirmed that the five-factor solution provided the best fit for the data with a p-value of 0.703 and factor loadings greater than 0.3.

The team validated the survey and found that it had a moderate internal consistency with a Cronbach alpha coefficient (α) of 0.50 to 0.77.

Study findings

The participants self-reported their race in the survey. Consequently, of the total 295 unvaccinated pregnant participants who filled the survey, 9.5% declared themselves Hispanic, 15.9% as non-Hispanic Black, and 74.2% as non-Hispanic White. The mean age of the survey participants was 30.8 years, and 56.6% received the COVID-19 vaccine during pregnancy.

The respondents who eventually got vaccinated self-identified as educated with higher household income, non-Hispanic White, and married. Compared to unvaccinated respondents, they had a favorable attitude towards vaccination (in general). They preferred to receive their annual influenza vaccine and accepted vaccination for their children.

The majority of unvaccinated survey respondents raised concerns over the long-term effects of COVID-19 vaccine and research to support vaccination in pregnancy. The vaccinated and unvaccinated pregnant groups had different views about vaccine efficacy. Accordingly, 34.1% of vaccinated respondents and 13.3% of unvaccinated respondents believed vaccines offered protection against SARS-CoV-2 infection.

Interestingly, 80.2% of vaccinated vs. 42.2% of unvaccinated respondents believed that the COVID-19 vaccine conferred protection to family members of the SARS-CoV-2-infected individuals. Likewise, 61.7% of vaccinated vs. 32.8% of unvaccinated respondents believed that vaccine passed on immunity to the infant.

The maternal belief that the vaccine will confer immunity to the infant markedly increased the odds for vaccination in a multivariate regression model, with an adjusted odds ratio (aOR) of 3.82, 95% CI. Conversely, concerns about the long-term effects of the vaccine continued to be an important factor against vaccination among pregnant women, with aOR =0.28, 95% CI.

Conclusions

Based on the survey responses, the study identified two primary concerns related to COVID-19 vaccines among pregnant people. This subset of the population appeared highly concerned primarily with the long-term effects of COVID-19 vaccines and the ability of these vaccines to pass immunity to the infant.

Therefore, based on these findings, the authors recommended targeting interventions to address vaccine hesitancy in pregnant women. For instance, they supported running public health campaigns in the US, at both local and national levels, that could make growing scientific data showing anti-SARS-CoV-2 antibody transfer via placenta and breastmilk following COVID-19 vaccination to pregnant women and their doctors.

Moreover, the researchers emphasized continuing research in the area to ascertain and publish concrete evidence of the long-term effects of COVID-19 vaccines for pregnant women and their infants.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Inhibition of Protein N-Glycosylation Blocks SARS-CoV-2 Infection. Image Credit: Kateryna Kon / Shutterstock.com

N-glycosylation blockers reduce SARS-CoV-2 infection

by Medical Finance
May 21, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the spike antigens on its surface to mediate host cell attachment...

Study: SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine. Image Credit: Fit Ztudio/Shutterstock

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

by Medical Finance
May 21, 2022
0

The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in South Africa in November 2021....

Study: Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges. Image Credit: Dotted Yeti / Shutterstock.com

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

by Medical Finance
May 21, 2022
0

As of February 22, 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 427 million individuals and...

Study: Review of Virus Inactivation by Visible Light. Image Credit: creativeneko/Shutterstock

Photoinactivating effect of visible light on viruses

by Medical Finance
May 21, 2022
0

Despite implementing various control measures, there still appears to be no clear end of the current coronavirus disease 2019 (COVID-19)...

Study: Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. Image Credit: mailsonpignata/Shutterstock

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

by Medical Finance
May 22, 2022
0

To prevent infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or at minimum provide protection against severe complications associated...

Study: Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myeloma. Image Credit: David A Litman/Shutterstock

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

by Medical Finance
May 21, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated the immune responses induced by the messenger ribonucleic acid...

Next Post
Study: T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

Study: USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. Image Credit: Juan Gaertner / Shutterstock

USP22 crucial for type III interferon signaling and SARS-CoV-2 infection

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Abdominal Imaging Associates Body Composition with COVID-19 Severity. TaMaNKunG
    COVID-19 severity is correlated with body composition
  • Study: Innate immunity: the first line of defense against SARS-CoV-2. Image Credit: Kateryna Kon/Shutterstock
    Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply